Testosterone undecanoate is a long-acting injectable testosterone ester. The cited U.S. AVEED label limits use to adults who need testosterone replacement and for whom its benefits outweigh serious immediate injection-related risks.

Established. Review the research and limitations before relying on this record.

The ester is converted to testosterone, which activates androgen receptors and has tissue-specific conversion to dihydrotestosterone and estradiol.

AVEED is an intramuscular castor-oil formulation. Its prolonged delivery reflects depot release and ester hydrolysis, but this must not be extrapolated to a different product, route or unregulated preparation.

U.S. approval is for replacement in adult males with primary or hypogonadotropic hypogonadism. This does not establish benefit for bodybuilding, non-specific fatigue, or age-related hypogonadism without the labelled diagnostic context.

The AVEED label carries serious warnings for pulmonary oil microembolism and anaphylaxis after injection, with healthcare observation required after each administration. Other labelled risks include polycythaemia, venous thromboembolism, prostate effects, blood-pressure increases and abuse or dependence.

“Oil” is informal gym shorthand, not a pharmacological category. This record describes the cited regulated formulation or animal-drug status only; it is not a protocol, a product-quality endorsement, or a recommendation. Human and veterinary products are not interchangeable.